CLINICAL_TRIALS trial_result · 2024-03-05

Clinical Trial Update: Aggressive Antipyretics for Fever Reduction in CNS Malaria [Phase 2]

Phase 2 trial update on aggressive antipyretics for fever reduction in cerebral malaria with seizures; results completed and posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Rochester | Conditions: Malaria, Seizures | Phase 2 | Status: COMPLETED | Results posted: 2024-03-05